Pulmonary Effects of Antineoplastic Therapy

  • Andrea S. Hinkle
  • Cindy Proukou
  • Yuhchyau Chen
Part of the Pediatric Oncology book series (PEDIATRICO)


Lung Injury Clin Oncol Lung Volume Radiat Oncol Biol Phys Antineoplastic Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abid S, Malhotra V, Perry M (2001) Radiation induced and chemotherapy induced pulmonary injury. Curr Opin Oncol 13:1–16CrossRefPubMedGoogle Scholar
  2. 2.
    Ager S, Mahendra P, Richards EM, Bass G, Baglin TP, Marcus RE (1996) High-dose carmustine, etoposide and melphalan (BEM) with autologous stem cell transplantation: a dose-toxicity study. Bone Marrow Transplant 17:335–340PubMedGoogle Scholar
  3. 3.
    Anderson BS, Cogan BM, Keating MJ (1984) Subacute pulmonary failure complicating therapy with high dose ara-C in acute leukemia. Cancer 56:2181–2184Google Scholar
  4. 4.
    Anscher MS, Kong F-M, Andrews K (1998) Plasma transforming growth factor β1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41:1029–1035CrossRefPubMedGoogle Scholar
  5. 5.
    Antonadou D, Throuvalas N, Petridis A (2003) Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57:402–408CrossRefPubMedGoogle Scholar
  6. 6.
    Antonia SJ, Wagner H, Williams C (1995) Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage III A/B non-small cell carcinoma of the lung. Semin Oncol 22:34–37Google Scholar
  7. 7.
    Azoulay E, Herigault S, Levame M, Brochrd L, Schlemmer B, Harf A, Delclaux C (2003) Effect of granulocyte colony stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis. Crit Care Med 31:1442–1448CrossRefPubMedGoogle Scholar
  8. 8.
    Bauer KA, Skarin AT, Balikian JP (1983) Pulmonary complications associated with combination chemotherapy programs containing bleomycin. Am J Med 74:557–563CrossRefPubMedGoogle Scholar
  9. 9.
    Bellamy EZ, Husband JE, Blaquiere RM (1985) Bleomycin related lung damage: CT evidence. Radiology 156:155–158PubMedGoogle Scholar
  10. 10.
    Benoist MR, Lemerle J, Jean R, Rufin P, Scheinmann P, Paupe J (1982) Effects on pulmonary function of whole lung irradiation for Wilms’ tumor in children. Thorax 37:175–180PubMedGoogle Scholar
  11. 11.
    Bhalla KS, Wilczynski SW, Abushamaa AM, Petros WP (2000) Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support. Am J Resp Crit Care Med 161:17–25PubMedGoogle Scholar
  12. 12.
    Block M, Lachowiez RM, Rios C (1990) Pulmonary fibrosis associated with low-dose adjuvant methyl-CCNU. Med Pediatr Oncol 18:256–260PubMedGoogle Scholar
  13. 13.
    Blum RH, Carter SK, Agre K (1973) A clinical review of bleomycin — a new antineoplastic agent. Cancer 31:903–914PubMedGoogle Scholar
  14. 14.
    Bossi G, Cerveri I, Volpini E, Corsico A, Baio A, Corbella F, Klersy C, Arico M (1997) Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease. Ann Oncol 8[Suppl 1]:19–24CrossRefPubMedGoogle Scholar
  15. 15.
    Brizel DM, Wassernan TH, Henke M (2000) Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339–3345PubMedGoogle Scholar
  16. 16.
    Burger A, Loffler H, Bamberg M, Rodenmann HP (1998) Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol 73:401–408CrossRefPubMedGoogle Scholar
  17. 17.
    Cassady JR, Richter MP, Piro AJ (1975) Radiation-Adriamycin interactions: preliminary clinical observations. Cancer 36:946–949PubMedGoogle Scholar
  18. 18.
    Catane R, Schwade JG, Turrisi AT (1979) Pulmonary toxicity after radiation and bleomycin: a review. Int J Radiat Oncol Biol Phys 5:1513–1518PubMedGoogle Scholar
  19. 19.
    Chan PYM, Kagan AR, Byfteld JE (1979) Pulmonary complications of combined chemotherapy and radiotherapy in lung cancer. Front Radiat Ther Oncol 13:136–144Google Scholar
  20. 20.
    Chen Y, Okunieff P, Ahrendt SA (2003) Translational research in lung cancer. Semin Surg Oncol 21:205–219CrossRefPubMedGoogle Scholar
  21. 21.
    Chen Y, Rubin P, Williams J (2001) Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 49:641–648CrossRefPubMedGoogle Scholar
  22. 22.
    Chen Y, Williams J, Ding I (2002) Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12:26–33CrossRefPubMedGoogle Scholar
  23. 23.
    Common Terminology Criteria for Adverse Events (CTCAE) (2003) Version 3.0. US Department of Health and Human Services. National Institutes of Health, National Cancer InstituteGoogle Scholar
  24. 24.
    Cooper JA, Zitnik R, Matthay RA (1988) Mechanisms of drug-induced pulmonary disease. Ann Rev Med 39:395–404CrossRefPubMedGoogle Scholar
  25. 25.
    Cooper JAD, White DA. Matthay RA (1986) Drug induced pulmonary disease, part I. Cyto-toxic drugs. Am Rev Respir Dis 133:321–340PubMedGoogle Scholar
  26. 26.
    Couderc LJ, Stelianides S, Frachon I, Stern M, Epardeau B, Baumelou E, Caubarrere I, Hermine O (1999) Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases. Resp Med 93:65–68CrossRefGoogle Scholar
  27. 27.
    Davidson DE, Grenan MM, Sweeney TR (1980) Biological characteristics of some improved radioprotectors. In: Brady LW (ed) Radiation sensitizers. Masson, New York, pp 309–320Google Scholar
  28. 28.
    DeLana M, Guzzon A, Monfardini S (1972) Clinical radiologic and histopathologic studies on pulmonary toxicity induced by treatment with bleomycin. Cancer Chemother Rep 56:343–355Google Scholar
  29. 29.
    Dent RG (1982) Fatal pulmonary toxic effects of lomustine. Thorax 37:627–629PubMedGoogle Scholar
  30. 30.
    Doll DC, Ringenberg Q, Yarbo JW (1986) Vascular toxicity associated with antineoplastic agents. J Clin Oncol 4:1405–1417PubMedGoogle Scholar
  31. 31.
    Donat SM, Levy DA (1998) Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary? J Urol 160:1347–1352CrossRefPubMedGoogle Scholar
  32. 32.
    Einhom L, Krause M, Homback N (1976) Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer. Cancer 37:2414–2416PubMedGoogle Scholar
  33. 33.
    Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B/ Solin LJ, Wesson M (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122PubMedGoogle Scholar
  34. 34.
    Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, Robison LL (2002) Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol 20:1608–1616CrossRefPubMedGoogle Scholar
  35. 35.
    Emmons KM, Butterfield RM, Puleo E, Park ER, Mertens A, Gritz ER, Lahti M, Li FP (2003) Smoking among participants in the childhood cancer survivors cohort: the Partnership for Health Study. J Clin Oncol 21:189–196CrossRefPubMedGoogle Scholar
  36. 36.
    Engelstad RB (1940) Pulmonary lesions after roentgen and radium irradiation. Am J Roentgenol 43:676–681Google Scholar
  37. 37.
    Evans RF, Sagerman RH, Ringrose TL (1974) Pulmonary function following mantle field irradiation for Hodgkin's disease. Radiology 111:729–731PubMedGoogle Scholar
  38. 38.
    Fontán JP, Haddad GG (2004) St Louis respiratory pathophysiology. In: Behrman RE, Kliegman RM, Jenson H (eds) Nelson textbook of pediatrics. Elsevier, Amsterdam, pp 1362–1370Google Scholar
  39. 39.
    Fryer CJ, Hutchinson RJ, Krailo M (1990) Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the children cancer study group. J Clin Oncol 8:1971–1980PubMedGoogle Scholar
  40. 40.
    Fryer CJH, Fitzpatrick PJ, Rider WD (1978) Radiation pneumonitis: experience following a large single dose of radiation. Int J Radiat Oncol Biol Phys 4:931–936PubMedGoogle Scholar
  41. 41.
    Germon PA, Brady LW (1968) Physiologic changes before and after radiation treatment for carcinoma of the lung. JAMA 206:809–814CrossRefPubMedGoogle Scholar
  42. 42.
    Gilson AJ, Sahn SA (1985) Reactivation of bleomycin lung toxicity following oxygen administration. Chest 88:304–306PubMedGoogle Scholar
  43. 43.
    Glazer HS, Lee JKT, Levitt RG (1985) Radiation fibrosis: differentiation from recurrent tumor by MR imaging. Radiology 156:721–726PubMedGoogle Scholar
  44. 44.
    Graham MV, Burdy JA, Emami B (1999) Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 45:323–329CrossRefPubMedGoogle Scholar
  45. 45.
    Gross NJ (1977) Pulmonary effects of radiation therapy. Ann Intern Med 86:81–92PubMedGoogle Scholar
  46. 46.
    Gross NJ (1980) Experimental radiation pneumonitis IV. Leakage of circulatory proteins onto the alveolar surface. J Lab Clin Med 95:19–31PubMedGoogle Scholar
  47. 47.
    Gross NJ (1981) The pathogenesis of radiation-induced lung damage. Lung 159:115–125PubMedGoogle Scholar
  48. 48.
    Gunstream SR, Seidenfeld JJ, Sobonya RE (1983) Mitomycin associated lung disease. Cancer Treat Rep 67:301–304PubMedGoogle Scholar
  49. 49.
    Hakenjos L, Bamberg M, Rodemann HP (2000) TGF-β1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenoty. Int J Radiat Biol 76:503–509CrossRefPubMedGoogle Scholar
  50. 50.
    Hale GA, Marina NM, Jones-Wallace D, Greenwald CA (1999) Late effects of treatment for germ cell tumors during childhood and adolescence. J Pediatr Hematol Oncol 21:115–122CrossRefPubMedGoogle Scholar
  51. 51.
    Hallahan DF, Virudachlam S (1997) Intercellular adhesion molecule-1 knockout abrogates radiation induced pulmonary inflammation. Proc Natl Acad Sci USA 94:6432–6437CrossRefPubMedGoogle Scholar
  52. 52.
    Haupt HM, Hutchins GM, Moore GW (1981) Ara-C lung: non-cardiogenic pulmonary edema complicating cytosine-arabinoside therapy of leukemia. Am J Med 70:256–261CrossRefPubMedGoogle Scholar
  53. 53.
    Hay J, Shahriar S, Laurent G (1991) Mechanisms of bleomycin-induced lung damage. Arch Toxicol 65:81–94CrossRefPubMedGoogle Scholar
  54. 54.
    Hernando ML, Marks LB, Bentel GC (2001) Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51:650–659CrossRefPubMedGoogle Scholar
  55. 55.
    Higa GM, AlKhouri N, Auber ML (1997) Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin pulmonary toxicity: report of two cases and review of literature. Pharmacotherapy 17:1315–1321PubMedGoogle Scholar
  56. 56.
    Hirsch A, Vander Els N, Straus DJ, Gomez EG, Leung D, Portlock CS, Yahalom J (1996) Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease. J Clin Oncol 14:1297–1305PubMedGoogle Scholar
  57. 57.
    Hodson WA (1977) Development of the lung. Dekker, New YorkGoogle Scholar
  58. 58.
    Hoyt DG, Lazo JS (1992) Murine strain differences in acute lung injury and activation of poly(ADP-ribose) polymerase by in vitro exposure of lung slices to bleomycin. Am J Respir Ces Mol Biol 7:645–651Google Scholar
  59. 59.
    Inoue A, Kunitoh H, Sekine I (2001) Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 49:649–655CrossRefPubMedGoogle Scholar
  60. 60.
    Ishii Y, Kitamura S (1999) Soluble intercellular adhesion molecule-1 as an early detection marker for radiation pneumonitis. Eur Respir J 13:733–738CrossRefPubMedGoogle Scholar
  61. 61.
    Johnston CJ, Wright TW, Rubin P, Finkelstein JN (1998) Alterations in the expression of chemokine mRNA levels in fibrosis-resistant and-sensitive mice after thoracic irradiation. Exp Lung Res 4:321–337Google Scholar
  62. 62.
    Kaplan E, Sklar C, Wilmott R, Michaels S, Ghavimi F (1996) Pulmonary function in children treated for rhabdomyosarcoma. Med Pediatr Oncol 27:79–84CrossRefPubMedGoogle Scholar
  63. 63.
    Kataoka M, Kawamura M, Itoh H (1992) Ga-67 citrate scintigraphy for the early detection of radiation pneumonitis. Clin Nucl Med 17:27–31PubMedGoogle Scholar
  64. 64.
    Kawana A, Shioya S, Katoh H, Tsuji C, Tsuda M, Ohta Y (1997) Expression of intercellular adhesion molecule-1 on alveolar macrophages in the acute stage of radiation-induced lung injury in rats. Radiat Res 147:431–436PubMedGoogle Scholar
  65. 65.
    Keane TJ, van Dyk J, Rider WD (1981) Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation. Int J Radiat Oncol Bio Phys 7:1365–1370Google Scholar
  66. 66.
    Kharasch VS, Lipsitz S, Santis W, Hallowell JA, Goorin A (1996) Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors. Med Pediatr 27:85–91CrossRefGoogle Scholar
  67. 67.
    Komaki R, Lee JS, Kaplan B (2002) Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II–III non-small cell lung cancer: preliminary results. Semin Radiat Oncol 12:46–49CrossRefPubMedGoogle Scholar
  68. 68.
    Kwa SLS, Lebesque JV, Theuws JCM (1998) Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42:1–9CrossRefPubMedGoogle Scholar
  69. 69.
    Lazo JS, Merrill WW, Pham ET (1984) Bleomycin hydrolase activity in pulmonary cells. J Pharmacol Exp Ther 231:583–588PubMedGoogle Scholar
  70. 70.
    Lehne G, Lote K (1990) Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review. Ada Oncol 29:113–124Google Scholar
  71. 71.
    Leroy EP, Liebner EJ, Jensick RJ (1966) The ultrastructure of canine alveoli after supervoltage irradiation of the thorax. Lab Invest 15:1544–1558PubMedGoogle Scholar
  72. 72.
    Libshitz HI, Shuman LS (1984) Radiation induced pulmonary change: CT findings. J Comput Assist Tomogr 8:15–19PubMedGoogle Scholar
  73. 73.
    Libura J, Bettens F, Radkowski A, Tiercy JM, Piguet PF (2002) Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene. Eur Respir J 19:912–918CrossRefPubMedGoogle Scholar
  74. 74.
    Littman P, Meadows AT, Polgar G (1976) Pulmonary function in survivors of Wilms’ tumor: patterns of impairment. Cancer 37:2773–2776PubMedGoogle Scholar
  75. 75.
    Maasilta P, Hallman M, Taskinen E (1993) Bronchoalveolar lavage fluid findings following radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 26:117–123PubMedGoogle Scholar
  76. 76.
    Mah K, Poon PY, van Dyk J (1986) Assessment of acute radiation-induced pulmonary changes using computed tomography. J Comput Assist Tomogr 10:736–743PubMedGoogle Scholar
  77. 77.
    Mah K, van Dyk J, Keane T (1987) Acute radiation-induced pulmonary damage: a clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 13:179–188PubMedGoogle Scholar
  78. 78.
    Maisin JR (1974) The influence of radiation on blood vessels and circulation. HI. Ultrastructure of the vessel wall. Curr Top Radiat Res Q 10:29–57PubMedGoogle Scholar
  79. 79.
    Makipemaa A, Heino M, Laitnen L (1989) Lung function following treatment of malignant tumors with surgery, radiotherapy, or cyclophosphamide in childhood. Cancer 63:625–630PubMedGoogle Scholar
  80. 80.
    Marruchella A, Franco C, Garavaldi G, Uccelli M, Bottrighi P (2002) Bleomycin-induced upper lobe fibrosis: a case report. Tumori 88:414–416PubMedGoogle Scholar
  81. 81.
    McCrea ES, Diaconis JJN, Wade C (1981) Bleomycin toxicity simulating metastatic nodules to the lungs. Cancer 48:1096–1100PubMedGoogle Scholar
  82. 82.
    McDonald S, Rubin P, Phillips TL, Marks LB (1995) Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. J Radiat Oncol Biol Phys 31:1187–1203CrossRefGoogle Scholar
  83. 83.
    McGaughey DS, Nikcevich DA, Long GD, Vredenburgh JJ (2001) Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation. Biol Blood Marrow Transplant 7:274–278CrossRefPubMedGoogle Scholar
  84. 84.
    Mertens AC, Yasua Y, Liu Y, Stovall M (2002) Pulmonary complications in survivors of childhood and adolescent cancer. A report from the childhood cancer survivor study. Cancer 95:2431–2441CrossRefPubMedGoogle Scholar
  85. 85.
    Miller RW, Fusner JE, Fink R (1986) Pulmonary function abnormalities in long term survivors of childhood cancer. Med Pediatr Oncol 14:202–207PubMedGoogle Scholar
  86. 86.
    Mosher RB, McCarthy BJ (1998) Late effects in survivors of bone tumors. J Pediatr Oncol Nurs 15:72–84CrossRefPubMedGoogle Scholar
  87. 87.
    Moss WT, Haddy FJ, Sweany SK (1960) Some factors altering the severity of acute radiation pneumonitis: variation with cortisone, heparin and antibiotics. Radiology 75:50–54PubMedGoogle Scholar
  88. 88.
    Nadel J (2000) General principles and diagnostic approach. In: Murray JF, Nadel JA (eds) Textbook of respiratory medicine. Saunders, St Louis, pp 1173–1182Google Scholar
  89. 89.
    Nakayama Y, Makino S, Fukuda Y (1996) Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 34:459–467CrossRefPubMedGoogle Scholar
  90. 90.
    Neve V, Foot AB, Michon J, Fourquet A, Zucker JM, Boule M (1999) Longitudinal clinical and functional pulmonary follow-up after megatherapy, fractionated total body irradiation, and autologous bone marrow transplantation for metastatic neuroblastoma. Med Pediatr Oncol 32:170–176CrossRefPubMedGoogle Scholar
  91. 91.
    Nysom K, Holm K, Olsen JH, Hertz H, Hesse B (1998) Pulmonary function after treatment for acute lymphoblastic leukaemia in childhood. Br J Can 78:21–27Google Scholar
  92. 92.
    O'Driscoll BR, Hasleton PS, Taylor PM (1990) Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 323:378–382PubMedGoogle Scholar
  93. 93.
    O'Driscoll BR, Kalra S, Gattamaneni HR, Woodcock AA (1995) Late carmustine fibrosis. Age ate treatment may influence severity and survival. Chest 107:1355–1357PubMedGoogle Scholar
  94. 94.
    Ortiz LA, Lasky JA, Hamilton R (1998) Expression of TNF and the necessity for TNF receptors in bleomycin-induced lung injury in mice. Exp Lung Res 24:721–743PubMedGoogle Scholar
  95. 95.
    Osanto S, Bukman A, van Hoek F (1992) Long term effects of chemotherapy in patients with testicular cancer. J Clin Oncol 10:574–579PubMedGoogle Scholar
  96. 96.
    Parish JM, Muhm JR, Leslie KO (2003) Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation. Mayo Clin Proc 78:630–634PubMedGoogle Scholar
  97. 97.
    Penney DP, Rubin P (1977) Specific early fine structural changes in the lung following irradiation. Int J Radiat Oncol Biol Phys 2:1123–1132PubMedGoogle Scholar
  98. 98.
    Penney DP, Shapiro DL, Rubin P (1981) Effects of radiation on the mouse lung and potential induction of radiation pneumonitis. Virchows Arch B Cell Pathol 37:327–336Google Scholar
  99. 99.
    Penney DP, Siemann DW, Rubin P (1982) Morphologic changes reflecting early and late effects of irradiation of the distal lung of the mouse review. Scanning Microsc 1:413–4255Google Scholar
  100. 100.
    Perry DJ, Weiss RB, Taylor HG (1982) Enhanced bleomycin toxicity during acute renal failure. Cancer Treat Rep 66:592–593PubMedGoogle Scholar
  101. 101.
    Phillips T (1981) Pulmonary section-cardiorespiratory workshops. Cancer Clin Trial 4[Suppl]:45–52Google Scholar
  102. 102.
    Phillips TL, Margolis L (1972) Radiation pathology and the clinical response of lung and esophagus. Front Radiat Ther Oncol 6:254–273Google Scholar
  103. 103.
    Phillips TL, Wharam MD, Margolis LW (1975) Modification of radiation injury to normal/tissues by chemotherapeutic agents. Cancer 35:1678–1684PubMedGoogle Scholar
  104. 104.
    Phillips TL, Wyatt JP (1980) Radiation fibrosis. In: Fishman AP (ed) Pulmonary diseases and disorders, vol 1. McGraw-Hill, New YorkGoogle Scholar
  105. 105.
    Post M, Copland I (2002) Overview of lung development. Acta Pharmacol Sin 23[Suppl]:4–7Google Scholar
  106. 106.
    Prato FS, Kurdyak R, Saibil EA (1977) Physiological and radiographic assessment during the development of pulmonary radiation fibrosis. Radiology 122:389–397PubMedGoogle Scholar
  107. 107.
    Prato FS, Kurdyak R, Saibil EA (1977) Regional and total lung function in patients following pulmonary irradiation. Invest Radio 12:224–237Google Scholar
  108. 108.
    Rabinowiiz M, Souhami L, Gil RA (1990) Increased pulmonary toxicity with bleomycin and cisplatin chemotherapy combinations. Am J Clin Oncol 13:132–138PubMedGoogle Scholar
  109. 109.
    Reckzeh B, Merte H, Pflluger K-H (1996) Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small cell lung cancer. J Clin Oncol 14:1071–1076PubMedGoogle Scholar
  110. 110.
    Roach M, Gandara D, You H-S (1995) Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 13:2606–2612PubMedGoogle Scholar
  111. 111.
    Roberts CM, Foulcher E, Zaunders JJ (1993) Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med 118:696–700PubMedGoogle Scholar
  112. 112.
    Robnett TJ, Machtay M, Vines EF (2000) Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48:89–94CrossRefPubMedGoogle Scholar
  113. 113.
    Rubin P (1977) Radiation toxicity: quantitative radiation pathology for predicting effects. Cancer 39[Suppl 2]:729–736PubMedGoogle Scholar
  114. 114.
    Rubin P (1984) The Franz Busche lecture: late effects of chemotherapy and radiation therapy: a new 7 hypothesis. Int J Radiat Oncol Biol Phys 10:5–34PubMedGoogle Scholar
  115. 115.
    Rubin P, Finkelstein J, McDonald S (1991) The identification of new early molecular mechanisms in the pathogenesis of radiation induced pulmonary fibrosis. Int J Radiat Oncol Biol Phys 21[Suppl I]:163 (abstract)Google Scholar
  116. 116.
    Rubin P, Finkelstien J, Shapiro D (1992) Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys 24:93–101PubMedGoogle Scholar
  117. 117.
    Rubin P, Johnston CJ, Williams JP (1995) A perpetual cascade of cytokines post-irradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33:99–109CrossRefPubMedGoogle Scholar
  118. 118.
    Rubin P, Shapiro DL, Finklestein JN (1980) The early release of surfactant following lung irradiation of alveolar type II cells. Int J Radiat Oncol Biol Phys 6:75–77PubMedGoogle Scholar
  119. 119.
    Rubin P, Siemann DW, Shapiro DL (1983) Surfactant release as an early measure of radiation pneumonitis. Int J Radiat Oncol Biol Phys 9:1669–1673PubMedGoogle Scholar
  120. 120.
    Samuels ML, Douglas EJ, Holoye PV (1976) Large dose bleomycin therapy and pulmonary toxicity. JAMA 235:1117–1120CrossRefPubMedGoogle Scholar
  121. 121.
    Schuchter L, Glick J (1993) The current status of WR-2721 (amifostine): a chemotherapy and radiation therapy protector. Biol Ther Cancer Update 1:1–10Google Scholar
  122. 122.
    Schwarz MI, King TE, Cherniack RM (2000) Principles of and approach to the patient with interstitial lung disease. In: Murray JF, Nadel JA (eds) Textbook of respiratory medicine. Saunders, St Louis, pp 1649–1670Google Scholar
  123. 123.
    Segawa Y, Takigawa N, Kataoka M (1997) Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys 39:91–98CrossRefPubMedGoogle Scholar
  124. 124.
    Selker RG, Jacobs SA, Moore PB (1980) 1,3-Bis (2-chloroethyl)-l-nitrosourea (BCNU)-induced pulmonary fibrosis. Neurosurgery 7:560–565PubMedGoogle Scholar
  125. 125.
    Shaw NJ, Tweeddale PM, Eden OB (1989) Pulmonary function in childhood leukemia survivors. Med Pediatr Oncol 17:149–154PubMedGoogle Scholar
  126. 126.
    Shrivastava PN, Hans L, Concannon JP (1974) Changes in pulmonary compliance and production of fibrosis in x-irradiated lungs of rats. Radiology 112:439–440PubMedGoogle Scholar
  127. 127.
    Siemann DW, Hill RP, Penney DP (1982) Early and late pulmonary toxicity in mice evaluated 180 and 420 days following localized lung irradiation. Radiat Res 89:396–407PubMedGoogle Scholar
  128. 128.
    Siemann DW, Rubin P, Penney DP (1986) Pulmonary toxicity following multi-fraction radiotherapy. Br J Cancer 53:365–367Google Scholar
  129. 129.
    Simon G, Reiol L, Tanner SM (1972) Growth of radiobiologically determined heart diameter, lung width and lung lengths from 5–(19 years with standard for clinical use. Arch Dis Child 47:373–382PubMedGoogle Scholar
  130. 130.
    Sleijfer S, van der Mark TW, Schraffordt Koops H, Mulder NH (1996) Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin. Eur J Cancer 32A:550–552CrossRefPubMedGoogle Scholar
  131. 131.
    Sostman HD, Matthay RA, Puinam CE (1976) Methotrexate induced pneumonitis. Medicine 55:371–389PubMedGoogle Scholar
  132. 132.
    Spector I, Zimbler H, Ross S (1979) Early-onset cyclophosphamide induced interstitial pneumonitis. JAMA 242:2852–2854CrossRefPubMedGoogle Scholar
  133. 133.
    Stewart P, Buckner CD, Thomas ED (1983) Intensive chemotherapy with autologous marrow transplantation for small cell carcinoma of the lung. Cancer Treat Rep 7:1055–1059Google Scholar
  134. 134.
    Theise ND, Henegariu O, Grove J, Jagirdar J, Kao PN, Crawford JM, Badve S, Saxena R, Krause DS (2002) Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp Hematol 30:1333–1338CrossRefPubMedGoogle Scholar
  135. 135.
    Thurlbeck WM (1975) Postnatal growth and development of the lung. Am Rev Respir Dis 111:803–843PubMedGoogle Scholar
  136. 136.
    Thurlbeck WM (1988) In: Murray JF, Nadel JA (eds) Textbook of respiratory medicine. Saunders, PhiladelphiaGoogle Scholar
  137. 137.
    Travis EL (1980) Early indicators of radiation injury on the lung: are they useful predictors for late changes? Int J Radiat Oncol Biol Phys 6:1267–1269PubMedGoogle Scholar
  138. 138.
    Travis EL, Hanley RA, Fenn JO (1977) Pathologic changes in the lung following single and multi-fraction irradiation. Int J Radiat Oncol Biol Phys 2:475–490PubMedGoogle Scholar
  139. 139.
    Tyc VL, Rai SN, Lensing S, Klosky JL, Stewart DB, Gattuso J (2003) Intervention to reduce intentions to use tobacco among pediatric cancer survivors. J Clin Oncol 21:1366–1372CrossRefPubMedGoogle Scholar
  140. 140.
    Van Barneveld PWC, Veenstra G, Sleifer DT (1985) Changes in pulmonary function during and after bleomycin treatment in patients with testicular carcinoma. Cancer Chemother Pharmacol 14:168–171CrossRefPubMedGoogle Scholar
  141. 141.
    Van Dyk J, Hill RP (1983) Postirradiation lung density changes measured by computerized tomography. Int J Radiat Oncol Biol Phys 9:847–852PubMedGoogle Scholar
  142. 142.
    Verschoore J, Lagrange JL, Boublil JL (1987) Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer. Radiother Oncol 9:281–288PubMedGoogle Scholar
  143. 143.
    Vieras F, Bradley EW, Alderson PO (1983) Regional pulmonary function after irradiation of the canine lung: radionuclide evaluation. Radiology 147:839–844PubMedGoogle Scholar
  144. 144.
    Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, Dewhirst MW, Haroon ZA (2001) Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 50:851–855CrossRefPubMedGoogle Scholar
  145. 145.
    Wall MA, Wohl MEB, Jaffe N (1979) Lung function in adolescents receiving high dose methotrexate. Pediatrics 63:741–746PubMedGoogle Scholar
  146. 146.
    Wara WM, Phillips TL, Margolis LW (1973) Radiation pneumonitis: a new approach to the derivation of time-dose factors. Cancer 32:547–552PubMedGoogle Scholar
  147. 147.
    Ward WT, Molteni A, Solliday SH (1985) The relationship between endothelial dysfunction and collagen accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 11:1985–1990PubMedGoogle Scholar
  148. 148.
    Wasserman TH, Phillips TL, Ross G (1981) Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by WR-2721. Cancer Clin Trials 4:3–6PubMedGoogle Scholar
  149. 149.
    Weichselbaum RR, Awan AM (1987) Principles of radiation oncology. In: Bitran JD et al. (eds) Lung cancer-a comprehensive treatise. Grune and Stratton, OrlandoGoogle Scholar
  150. 150.
    Weinstein AS, Diener-West M, Nelson DF (1986) Pulmonary toxicity of carmustine in patients treated for malignant glioma. Cancer Treat Rep 70:943–946PubMedGoogle Scholar
  151. 151.
    White DA, Stover DE (1984) Severe bleomycin induced pneumonitis. Clinical features and response to corticosteroids 86:723–728Google Scholar
  152. 152.
    Whitneld AGW, Bond WH, Kunkler PB (1963) Radiation damage to thoracic tissues. Thorax 18:371–380PubMedGoogle Scholar
  153. 153.
    Wohl ME, Griscom NT, Traggis DG, Jaffe N (1975) Effects of therapeutic irradiation delivered in early childhood upon subsequent lung function. Pediatrics 55:507–516PubMedGoogle Scholar
  154. 154.
    Yuhas JM, Spellman JM, Jordan SW (1980) Treatment of tumours with the combination of WR-2721 and cisdichlorodiammineplatinum(II) or cyclophosphamide. Br J Cancer 42:574–585PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Andrea S. Hinkle
  • Cindy Proukou
  • Yuhchyau Chen

There are no affiliations available

Personalised recommendations